COMPARATIVE ANALYSIS OF FETOMATERNAL OUTCOMES IN PREGNANT WOMEN WITH THROMBOCYTOPENIA DURING DELIVERY: A ONE-YEAR STUDY AT A TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Thrombocytopenia, Blood Transfusion, Gestational Thrombocytopenia
Abstract
Objective: The present study evaluated fetomaternal outcomes in pregnant females with thrombocytopenia.
Materials and Methods: This comparative study involved pregnant women with and without thrombocytopenia admitted into labour. The study assessed aetiology, maternal morbidities such as intrapartum and postpartum haemorrhage, the need for blood and blood product transfusions, Medical Intensive Care Unit (MICU) admissions, maternal mortality, and neonatal outcomes, including morbidity and mortality rates. Particular attention was paid to the rate of preterm deliveries and NICU admissions in thrombocytopenic patients.
Results: The blood and blood product transfusion requirement were significantly higher in the thrombocytopenia group than in controls. No significant differences were observed between groups in terms of gravid status, mode of delivery, antepartum haemorrhage (APH), postpartum haemorrhage (PPH), APGAR scores, intrauterine growth restriction (IUGR), NICU admissions, or stillbirth rates. Thrombocytopenia was most frequently gestational in origin and did not generally affect maternal or neonatal outcomes. However, in cases where thrombocytopenia was associated with conditions such as preeclampsia or HELLP syndrome, interventions were often necessary. Preterm delivery, NICU admission, and the need for transfusions were more common in the thrombocytopenia group.
Conclusion and Recommendation: A multidisciplinary approach involving obstetricians, medical intensivists, haematologists, and neonatologists ensures favourable maternal and neonatal outcomes in thrombocytopenia cases. Early detection and timely management of thrombocytopenia are key to preventing complications.
References
2. Burtt S. Reproductive responsibilities: Rethinking the fetal rights debate. Policy Sciences. 1994 Jun 1;27(2-3):179-96.
3. World Health Organization. Counselling for maternal and newborn health care: a handbook for building skills. Geneva: World Health Organization; 2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304190/ [Accessed 2024 Oct 12].
4. Centers for Disease Control and Prevention. Reproductive health. CDC. Available from: https://www.cdc.gov/reproductive-health/about/index.html [Accessed 2024 Oct 12].
5. World Health Organization. Maternal mortality. WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality [Accessed 2024 Oct 12].
6. Ciobanu AM, Colibaba S, Cimpoca B, Peltecu G, Panaitescu AM. Thrombocytopenia in Pregnancy. Maedica (Bucur). 2016 Mar;11(1):55-60.
7. Abu-Ouf NM, Jan MM. The impact of maternal iron deficiency and iron deficiency anemia on child's health. Saudi Med J. 2015 Feb;36(2):146-9.
8. Juan P, Stefano G, Antonella S, Albana C. Platelets in pregnancy. J Prenat Med. 2011 Oct;5(4):90-2.
9. Townsley DM. Hematologic complications of pregnancy. InSeminars in hematology 2013 Jul 1 (Vol. 50, No. 3, pp. 222-231). WB Saunders.
10. Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. Indian Journal of Hematology and Blood Transfusion. 2012 Jun 1;28(2):77-81.
11. Jung JH, Soh MS, Ahn YH, Um YJ, Jung JY, Suh CH, Kim HA. Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients. Medicine (Baltimore). 2016 Feb;95(6):e2818.
12. Kapadiya SN, Patel HS, Parmar KG. Effects of thrombocytopenia in pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2018;7(3):1044-7
13. Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R. Moderate to severe thrombocytopenia during pregnancy. European Journal of Obstetrics & Gynecology and reproductive biology. 2006 Sep 1;128(1-2):163-8.
14. Vishwekar PS, Yadav RK, Gohel CB. Thrombocytopenia during pregnancy and its outcome: a prospective study. J Krishna Inst Med Sci Univ. 2017 Jan 1;6(1):82-9.
15. Chauhan V, Gupta A, Mahajan N, Vij A, Kumar R, Chadda A. Maternal and fetal outcome among pregnant women presenting with thrombocytopenia. Int J Reprod Contracept Obstet Gynecol 2016;5:2736-43.
16. Nazeer RM, Patil MA. Thrombocytopenia in pregnancy and its correlation with maternal and fetal outcome. Journal of Critical Reviews. 2020;7(12):749-52.
17. Brohi ZP, Perveen U, Sadaf A. Thrombocytopenia in pregnancy: an observational study. Pak J Med. 2013; 52 (3): 67-70
18. Vyas R, Shah S, Yadav P, Patel U. Comparative study of mild versus moderate to severe thrombocytopenia in third trimester of pregnancy in a tertiary care hospital. NHL J Med Sci. 2014;3(1):8-11.
19. Yuce T, Acar D, Kalafat E, Alkilic A, Cetindag E, Soylemez F. Thrombocytopenia in pregnancy: do the time of diagnosis and delivery route affect pregnancy outcome in parturients with idiopathic thrombocytopenic purpura? Int J Hematol. 2014 Dec 1;100(6):540-4.
20. Carles G, Talarmin A, Peneau CH, Bertsch M. Dengue fever and pregnancy. A study of 38 cases in French Guiana. Journal de gynecologie, obstetrique et biologie de la reproduction. 2000 Dec;29(8):758-62.
21. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003 Dec 15;102(13):4306-11.